Viewing data from:

INCASSIA

ANDA

NORETHINDRONE | A207304 | AUROBINDO PHARMA LTD

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: NOR-QD(TE code: AB1)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.0943

per ea

Lowest NADAC/Unit

$0.0943

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
65862092528INCASSIA 0.35 MG TABLET	$0.0943	EA	Generic	—	2026-06-17
65862092585INCASSIA 0.35 MG TABLET	$0.0943	EA	Generic	—	2026-06-17
50102030013LYLEQ 0.35 MG TABLET	$0.0943	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

Medicare Part D Spending

CMS annual spending data for Incassia (2024)

Total Spending

$89K

Total Claims

3,887

Beneficiaries

1,425

Avg Cost/Unit

$0.38

Spending Trend

$660.18(2019)→$72K(2020)→$116K(2021)→$103K(2022)→$102K(2023)→$89K(2024)

YoY Change:-23.9%

5yr CAGR:-11.0%

Source: CMS Medicare Part D Spending by Drug (2024). Shows gross drug cost under Part D.

API Supply Chain7 active DMFs9 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

DR REDDYS LABORATORIES LTDNORETHINDRONE

DMF 2401957

BAYER AGNORETHINDRONE

DMF 27261976

ASPEN OSS BVNORETHINDRONE

DMF 38491980

LUPIN LTDNORETHINDRONE USP

DMF 225052009

VALDEPHARMNORETHINDRONE

DMF 244162011

NAARI PTE LTDNORETHINDRONE

DMF 358032021

ARESKO LIFE SCIENCES PRIVATE LTDNORETHINDRONE USP

DMF 422272025

ROUSSEL CORPInactiveNORETHINDRONE

DMF 19201972

MITSUBISHI CHEMICAL CORPInactiveNORETHINDRONE, BULK

DMF 29831977

GEDEON RICHTER LTDInactiveNORETHINDRONE 1 MG. AND MESTRANOL 0.05 MG. TABLETS IN BULK

DMF 66391986

GEDEON RICHTER LTDInactiveNORETHINDRONE 1 MG. AND ETHINYL ESTRADIOL 0.035 MG. USP TABS.

DMF 66601986

GEDEON RICHTER LTDInactiveNORETHINDRONE 0.5 MG. AND ETHINYL ESTRADIOL 0.035

DMF 73321988

GEDEON RICHTER LTDInactiveNORETHINDRONE 0.75 MG. AND ETHINYL ESTRADIOL 0.035 MG. TABLET

DMF 74661988

STOLLE RESEARCH AND DEVELOPMENT CORPInactiveNORETHINDRONE INJECTABLE MICROSPHERES - CINCINNATI, OHIO

DMF 75881988

ROUSSELL UCLAFInactiveNORETHINDRONE

DMF 82391989

ZHEJIANG XIANJU JUNYE PHARMACEUTICAL CO LTDInactiveNORETHINDRONE

DMF 241762010

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 0.35MG

AB1

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Sep 23, 2016

No patent or exclusivity listings for this strength.